Exploring SLC16A1 as an Oncogenic Regulator and Therapeutic Target in Cholangiocarcinoma
Jianxin Huang, Fahui Liu, Donghua Liu, Shihang Tang, Dong‐Yan Shen · Journal of Cancer · 2024
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2024
Abstract
experiments, we confirmed that SLC16A1, as an oncogene in CCA, promotes the growth of CCA cells and chemoresistance. Knocking down SLC16A1 inhibited the growth of CCA cells and enhanced their sensitivity to 5-Fluorouracil (5-FU). Overall, this study reveals the key role of SLC16A1 in the development of CCA and highlights its significance as a potential target for improving treatment efficacy and chemotherapy sensitivity.
Open the resolved locator · 10.7150/jca.95258
Metadata licence: OpenAlex metadata (CC0)